Published in J Cereb Blood Flow Metab on March 01, 2000
The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull (2009) 6.03
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A (2000) 3.34
Anatomically distinct dopamine release during anticipation and experience of peak emotion to music. Nat Neurosci (2011) 3.04
Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry (2011) 2.29
Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys. Neuropsychopharmacology (2008) 1.67
Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect (2010) 1.66
Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. J Neurosci (2011) 1.55
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects. Eur J Nucl Med Mol Imaging (2008) 1.55
Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry (2009) 1.53
Imaging the serotonin transporter during major depressive disorder and antidepressant treatment. J Psychiatry Neurosci (2007) 1.46
Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study. Clin Chim Acta (2015) 1.43
Stress, alcohol and drug interaction: an update of human research. Addict Biol (2008) 1.40
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab (2011) 1.36
The dopaminergic basis of human behaviors: A review of molecular imaging studies. Neurosci Biobehav Rev (2009) 1.30
The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology (2010) 1.18
Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging. Psychopharmacology (Berl) (2005) 1.17
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Eur J Neurosci (2005) 1.17
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) (2003) 1.16
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab (2010) 1.16
Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology (2009) 1.15
Striatal ups and downs: their roles in vulnerability to addictions in humans. Neurosci Biobehav Rev (2013) 1.14
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuroimage (2010) 1.12
Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain. Eur J Nucl Med Mol Imaging (2014) 1.11
5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev (2011) 1.10
Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry (2011) 1.10
A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Hum Mol Genet (2010) 1.09
When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine. Alcohol Clin Exp Res (2008) 1.08
Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction. Psychopharmacology (Berl) (2006) 1.08
Striatal dopamine release during performance of executive functions: A [(11)C] raclopride PET study. Neuroimage (2006) 1.07
Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study. Eur J Neurosci (2008) 1.05
Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography. Cereb Cortex (2013) 1.05
Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates. Front Aging Neurosci (2013) 1.04
In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates. Psychopharmacology (Berl) (2004) 1.03
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology (2008) 1.03
Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A (2013) 1.02
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology (2013) 1.01
Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use. Neuropsychopharmacology (2013) 0.99
Behavioral and neurobiological characteristics influencing social hierarchy formation in female cynomolgus monkeys. Neuroscience (2008) 0.98
Deep brain stimulation: technology at the cutting edge. J Clin Neurol (2010) 0.97
Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 dopamine receptors. Synapse (2009) 0.96
Dopamine D2 receptor density in the limbic striatum is related to implicit but not explicit movement sequence learning. Proc Natl Acad Sci U S A (2010) 0.96
Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse (2007) 0.95
Neuroimaging in Parkinson's disease. Neurotherapeutics (2011) 0.95
Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology (2010) 0.95
Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction? Biochem Pharmacol (2011) 0.94
Levodopa increases memory encoding and dopamine release in the striatum in the elderly. Neurobiol Aging (2006) 0.94
Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study. Neuroimage (2012) 0.94
Addiction: the clinical interface. Br J Pharmacol (2008) 0.94
Positron emission tomography and single-photon emission computed tomography in central nervous system drug development. NeuroRx (2005) 0.94
Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology (2013) 0.93
Neurophysiological and neurochemical animal models of schizophrenia: focus on glutamate. Behav Brain Res (2009) 0.93
Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging. Psychopharmacology (Berl) (2011) 0.93
Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol. Psychopharmacology (Berl) (2006) 0.93
Striatal dopamine in bulimia nervosa: a PET imaging study. Int J Eat Disord (2012) 0.92
Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics. Synapse (2010) 0.92
Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO. Neuropsychopharmacology (2014) 0.92
Striatal dopamine release and genetic variation of the serotonin 2C receptor in humans. J Neurosci (2012) 0.92
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease. Neurology (2009) 0.92
Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study. Mol Psychiatry (2013) 0.91
Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology (2013) 0.91
The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding. Neuroimage (2010) 0.91
A receptor-based model for dopamine-induced fMRI signal. Neuroimage (2013) 0.90
Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci (2013) 0.90
Occupancy of dopamine D2/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA. Synapse (2008) 0.90
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain (2013) 0.89
Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl) (2008) 0.89
Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.88
Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. Front Physiol (2012) 0.88
The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement. PLoS One (2013) 0.88
Contributions of neuroimaging to understanding sex differences in cocaine abuse. Exp Clin Psychopharmacol (2011) 0.88
Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp. Brain (2013) 0.87
Increased synaptic dopamine in the putamen in restless legs syndrome. Sleep (2013) 0.87
Neuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite. J Neuroendocrinol (2010) 0.87
Postpartum and depression status are associated with lower [[¹¹C]raclopride BP(ND) in reproductive-age women. Neuropsychopharmacology (2012) 0.86
Simultaneous fMRI-PET of the opioidergic pain system in human brain. Neuroimage (2014) 0.86
Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us? World Psychiatry (2003) 0.86
Applications of positron emission tomography (PET) in neurology. J Neurol Neurosurg Psychiatry (2004) 0.86
Limitations of SRTM, Logan graphical method, and equilibrium analysis for measuring transient dopamine release with [(11)C]raclopride PET. Am J Nucl Med Mol Imaging (2013) 0.85
[Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system]. Schmerz (2007) 0.85
What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum. Neurosci Lett (2007) 0.85
Relationship between impulsivity, prefrontal anticipatory activation, and striatal dopamine release during rewarded task performance. Psychiatry Res (2014) 0.85
Nonhuman primate positron emission tomography neuroimaging in drug abuse research. J Pharmacol Exp Ther (2011) 0.85
Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat. Psychopharmacology (Berl) (2008) 0.85
Assessing the sensitivity of [¹¹C]p943, a novel 5-HT1B radioligand, to endogenous serotonin release. Synapse (2011) 0.85
Prefrontal dopaminergic receptor abnormalities and executive functions in Parkinson's disease. Hum Brain Mapp (2012) 0.84
Nonhuman primate neuroimaging and the neurobiology of psychostimulant addiction. Ann N Y Acad Sci (2008) 0.84
The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab (2012) 0.84
Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence. Front Psychiatry (2013) 0.84
Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. Neuroimage (2009) 0.84
Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates. Bioorg Med Chem (2013) 0.84
Microfluidics for positron emission tomography probe development. Mol Imaging (2010) 0.84
Pathway-Specific Dopamine Abnormalities in Schizophrenia. Biol Psychiatry (2016) 0.83
Mapping brain function in freely moving subjects. Neurosci Biobehav Rev (2004) 0.83
Neuroimaging and drug taking in primates. Psychopharmacology (Berl) (2011) 0.83
Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition. Curr Neuropharmacol (2009) 0.83
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder. Int J Neuropsychopharmacol (2013) 0.83
1-Methyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine with unexpected mechanism of action: new vistas of therapeutic application. Neurotox Res (2013) 0.82
Neurofunctional imaging of β-cell dynamics. Diabetes Obes Metab (2012) 0.82
Ratio of dopamine synthesis capacity to D2 receptor availability in ventral striatum correlates with central processing of affective stimuli. Eur J Nucl Med Mol Imaging (2008) 0.82